Watch Ticker

Clene Inc. Common Stock

Go to Clene Inc. Common Stock Website

$0.38

(%)

Live

Previous Close

$0.3826

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$49.3 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseas...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Clene Inc. - Clene to Present at Upcoming May Conferences

SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis and multiple sclerosis, today announced that it will participate in the following investor conferences in May.

Related tickers: CLNN.

Read Full Article

Zacks Equity Research - Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates

Clene (CLNN) delivered earnings and revenue surprises of 0% and 54.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: CLNN, FOLD.

Read Full Article

Trending Tickers

BTTX

XNAS

$0.01

0.00 (-26.17%)

OPRT

XNAS

$3.92

-0.31 (-7.33%)

PALI

XNAS

$6.38

0.14 (2.24%)

PRSO

XNAS

$1.39

-0.03 (-2.11%)

ACRV

XNAS

$8.65

0.29 (3.47%)